Rite Aid Corp.

NYSE:RAD  
8.71
+0.66 (+8.20%)
Positive Earnings Pre-Announcement

Rite Aid Reports Q1 Net Loss Per Share Of $2.03

Published: 06/23/2022 11:15 GMT
Rite Aid Corp. (RAD) - Oration Reports Fiscal 2023 First Quarter Results.
Q1 Revenue $6.01 Billion Versus $6.16 Billion.
Qtrly Net Loss per Share of $2.03.
Increases Fiscal 2023 Revenue and Maintains Fiscal 2023 Adjusted EBITDA Guidance.
Qtrly Adjusted Net Loss per Share of $0.60.
Pharmacy Services Segment Revenues Were $1.7 Billion for Quarter, a Decrease of 7.8 Percent Compared to Prior Year Quarter.
Total Revenues Are Expected to Be Between $23.6 Billion and $24.0 Billion in Fiscal 2023.
Net Loss is Expected to Be Between $246.3 Million and $203.3 Million in Fiscal 2023.
Adjusted EBITDA is Expected to Be Between $460 Million and $500 Million in Fiscal 2023.
Qtrly Retail Pharmacy Segment Revenues Decreased 0.1 Percent Over Prior Year Quarter.
Adjusted Net Loss per Share is Expected to Be Between $1.19 and $0.66 for Fiscal 2023.
Qtrly Retail Pharmacy Same Store Sales for Q1 Increased 4.6 Percent Over Prior Year Period.
Expect to Generate Positive Free Cash Flow in Fiscal 2023.
Capital Expenditures Are Expected to Be About $250 Million for Fiscal 2023.
Retail Pharmacy Segment Revenue is Expected to Be Between $17.35 Billion and $17.65 Billion for Fiscal 2023.
Qtrly Retail Pharmacy Front-end Same Store Sales, Excluding Cigarettes and Tobacco Products, Were Flat.
Pharmacy Services Segment Revenue is Expected to Be Between $6.25 Billion and $6.35 Billion for Fiscal 2023.
FY2023 Earnings per Share View $-1.41, Revenue View $22.91 Billion -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $5.68 Billion
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $5.77 Billion
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.